Skip to main content

levonorgestrel (Benilexa®)

 

Status: Medicine does not meet criteria for AWMSG assessment

Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information.

 

Medicine details

Medicine name levonorgestrel (Benilexa®)
Formulation 20 micrograms/24 hours intrauterine delivery system
Reference number 5038
Indication

Contraception. Treatment of heavy menstrual bleeding

Company Gedeon Richter (UK) Ltd
BNF chapter Obstetrics, gynaecology & urinary tract disorders
Assessment type N/A
Status Medicine does not meet criteria for AWMSG assessment
Date of issue 11/01/2022
Follow AWTTC: